A recent laboratory study based on specimens from 766 US patients with vaginal symptoms evaluates the performance of the current US FDA (Federal Drugs Administration) approved diagnostic test for Trichomonas Vaginalis (BD Affirm VPIII hybridization) against a modern molecular amplification based test (Gen-Probe Aptima). The greater sensitivity of the new test emerges clearly in this … Continue reading Just supposing Trichomonas Vaginalis proved not to be an exclusively sexually transmitted infection after all …… ? […]
0 Comments